From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD)
出版年份 2021 全文链接
标题
From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD)
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 19, Pages 13980-14010
出版商
American Chemical Society (ACS)
发表日期
2021-10-01
DOI
10.1021/acs.jmedchem.1c00787
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery
- (2021) Lyra Chang et al. Scientific Reports
- Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials
- (2021) Yanli Sun et al. Frontiers in Pharmacology
- Annual review of LSD1/KDM1A inhibitors in 2020
- (2021) Dong-Jun Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2
- (2021) Renato Ferreira de Freitas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone crotonylation-centric gene regulation
- (2021) Kun Li et al. Epigenetics & Chromatin
- Chemical biology of protein citrullination by the protein A arginine deiminases
- (2021) Santanu Mondal et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Fragments: where are we now?
- (2020) James Osborne et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Advances in histone demethylase KDM4 as cancer therapeutic targets
- (2020) Dong Hoon Lee et al. FASEB JOURNAL
- Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
- (2020) Emily J. Faivre et al. NATURE
- The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
- (2020) Hope S. Rugo et al. ADVANCES IN THERAPY
- Substituted 1-methyl-4-phenylpyrrolidin-2-ones – Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors
- (2020) J.P. Hilton-Proctor et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors
- (2020) Zizhou Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of WD Repeat-Containing Protein 5 (WDR5)–MYC Inhibitors Using Fragment-Based Methods and Structure-Based Design
- (2020) Selena Chacón Simon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel pyrrolopyridone bromodomain and extra-terminal motif (BET) inhibitors effective in endocrine-resistant ER+ breast cancer with acquired resistance to fulvestrant and palbociclib
- (2020) Yangfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
- (2020) George S. Sheppard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype
- (2020) Christopher R. Wellaway et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic Therapies for Cancer
- (2020) Susan E. Bates NEW ENGLAND JOURNAL OF MEDICINE
- Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities
- (2020) Sarder Arifuzzaman et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
- (2020) Ewelina Kulikowski et al. MEDICINAL RESEARCH REVIEWS
- Combined Protein- and Ligand-Observed NMR Workflow to Screen Fragment Cocktails against Multiple Proteins: A Case Study Using Bromodomains
- (2020) Jorden A. Johnson et al. MOLECULES
- Covalent inhibition of NSD1 histone methyltransferase
- (2020) Huang Huang et al. Nature Chemical Biology
- Fragment-to-Lead Medicinal Chemistry Publications in 2019
- (2020) Wolfgang Jahnke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone benzoylation serves as an epigenetic mark for DPF and YEATS family proteins
- (2020) Xiangle Ren et al. NUCLEIC ACIDS RESEARCH
- A patent review of arginine methyltransferase inhibitors (2010-2018)
- (2019) Xiao Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity
- (2019) Erin R. Aho et al. Cell Reports
- Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription
- (2019) Claire E. Barnes et al. Essays in Biochemistry
- A chemical toolbox for the study of bromodomains and epigenetic signaling
- (2019) Qin Wu et al. Nature Communications
- Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
- (2019) Jark Böttcher et al. Nature Chemical Biology
- The regulation, functions and clinical relevance of arginine methylation
- (2019) Ernesto Guccione et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
- (2019) Sarina A. Piha-Paul et al. CLINICAL CANCER RESEARCH
- DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs
- (2019) Jie Yu et al. DRUG DISCOVERY TODAY
- The diverse roles of DNA methylation in mammalian development and disease
- (2019) Maxim V. C. Greenberg et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Concepts and Core Principles of Fragment-Based Drug Design
- (2019) Philine Kirsch et al. MOLECULES
- Targeting non-bromodomain chromatin readers
- (2019) Cheryl H. Arrowsmith et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Histone lysine methyltransferases in biology and disease
- (2019) Dylan Husmann et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Synthesis and elaboration of N-methylpyrrolidone as an acetamide fragment substitute in bromodomain inhibition
- (2019) J.P. Hilton-Proctor et al. BIOORGANIC & MEDICINAL CHEMISTRY
- DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
- (2019) Federica Sarno et al. Epigenetics
- Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core
- (2019) Jianhua Tian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design
- (2019) Soraya Alnabulsi et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Dichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic Diseases
- (2019) Pedro Gomes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The timeline of epigenetic drug discovery: from reality to dreams
- (2019) A. Ganesan et al. Clinical Epigenetics
- Targeting Ligandable Pockets on Plant Homeodomain (PHD) Zinc Finger Domains by a Fragment-Based Approach
- (2018) Anastasia Amato et al. ACS Chemical Biology
- BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
- (2018) Laura E. Jennings et al. BIOORGANIC & MEDICINAL CHEMISTRY
- ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
- (2018) Tamara Maes et al. CANCER CELL
- Chemical and Biochemical Perspectives of Protein Lysine Methylation
- (2018) Minkui Luo CHEMICAL REVIEWS
- Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains
- (2018) Andrea Dalle Vedove et al. ChemMedChem
- When fragments link: a bibliometric perspective on the development of fragment-based drug discovery
- (2018) Angelo K.S. Romasanta et al. DRUG DISCOVERY TODAY
- Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA
- (2018) Ke Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Potent 2-Aryl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design
- (2018) Feng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain
- (2018) Robert P. Law et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
- (2018) Duncan C. Miller et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Epigenetic drug discovery: a success story for cofactor interference
- (2018) A. Ganesan PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
- (2018) Hatice Gulcin Ozer et al. Cancer Discovery
- WD40 Repeat Proteins: Signalling Scaffold with Diverse Functions
- (2018) Buddhi Prakash Jain et al. PROTEIN JOURNAL
- Insights into the Biochemistry, Evolution, and Biotechnological Applications of the Ten-Eleven Translocation (TET) Enzymes
- (2018) Mackenzie J. Parker et al. BIOCHEMISTRY
- Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)
- (2018) David Heidenreich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functions and mechanisms of non-histone protein acetylation
- (2018) Takeo Narita et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Methyllysine binding domains: Structural insight and small molecule probe development
- (2017) Kelly A. Teske et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe
- (2017) Philip G. Humphreys et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
- (2017) Keith F. McDaniel et al. JOURNAL OF MEDICINAL CHEMISTRY
- GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
- (2017) F. Anthony Romero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors
- (2017) Le Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
- (2017) Loren M. Lasko et al. NATURE
- Chemical and structural biology of protein lysine deacetylases
- (2017) Minoru YOSHIDA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach
- (2017) Henrik Möbitz et al. ACS Medicinal Chemistry Letters
- Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains
- (2017) David S. Millan et al. ACS Medicinal Chemistry Letters
- A Chemical Probe for the ATAD2 Bromodomain
- (2016) Paul Bamborough et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
- (2016) Laetitia J. Martin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit
- (2016) Brian S. Gerstenberger et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
- (2016) Kevin W. Kuntz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
- (2016) Terry D. Crawford et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
- (2016) Brian K. Albrecht et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
- (2016) Terry D. Crawford et al. JOURNAL OF MEDICINAL CHEMISTRY
- An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
- (2016) Maia Vinogradova et al. Nature Chemical Biology
- Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)
- (2016) Alexander M. Taylor et al. ACS Medicinal Chemistry Letters
- Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket
- (2016) Clemens Scheufler et al. ACS Medicinal Chemistry Letters
- Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
- (2015) Paul Bamborough et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
- (2015) Peiling Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors
- (2015) Magdalena Korczynska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B
- (2015) Ludovic Drouin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
- (2015) Emmanuel H. Demont et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragments in bromodomain drug discovery
- (2015) Paul Bamborough et al. MedChemComm
- Methyl-CpG-binding domain proteins: readers of the epigenome
- (2015) Qian Du et al. Epigenomics
- The NSD family of protein methyltransferases in human cancer
- (2015) Theodore Vougiouklakis et al. Epigenomics
- A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes
- (2014) Arun Baksi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
- (2014) Mar Gacias et al. CHEMISTRY & BIOLOGY
- Fragment-Based Screening of the Bromodomain of ATAD2
- (2014) Mary J. Harner et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor
- (2014) Romain Gosmini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
- (2014) Duncan A. Hay et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Non-histone protein methylation as a regulator of cellular signalling and function
- (2014) Kyle K. Biggar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
- (2013) Fleur M. Ferguson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
- (2013) Lewis R. Vidler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
- (2013) David S. Hewings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tudor: a versatile family of histone methylation ‘readers’
- (2013) Rui Lu et al. TRENDS IN BIOCHEMICAL SCIENCES
- Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments
- (2013) James R. Hitchin et al. MedChemComm
- Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors
- (2013) Victor S. Gehling et al. ACS Medicinal Chemistry Letters
- From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
- (2012) Olivier Mirguet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
- (2012) Paul V. Fish et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
- (2011) David S. Hewings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides
- (2011) Paul Bamborough et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
- (2011) Martin Philpott et al. Molecular BioSystems
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started